Sign In
Buy CMMB
$1.72
-0.0200 (-1.15%)
At Close: Jun 03, 2026
Chemomab Announces Poster Presentation at the International Liver Congress 2021 (EASL)
07:00am, Thursday, 10'th Jun 2021
TEL AVIV, Israel, June 10, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fi
Chemomab Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
09:25am, Thursday, 13'th May 2021
TEL-AVIV, Israel, May 13, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibro
Chemomab to Present at Oppenheimer's Virtual Rare and Orphan Disease Summit
07:00am, Wednesday, 12'th May 2021
TEL AVIV, Israel, May 12, 2021 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibro
Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in Non-Alcoholic Steatohepatitis (NASH)
06:30am, Monday, 26'th Apr 2021
TEL-AVIV, Israel, April 26, 2021 /PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for f
Chemomab Therapeutics Stock Price Increased 111.13%: Why It Happened
09:40pm, Thursday, 08'th Apr 2021
The stock price of Chemomab Therapeutics Ltd (NASDAQ: CMMB) increased by 111.13%. This is why it happened.
